31 – 40 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study
(
- Contribution to journal › Article
-
Mark
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
(
- Contribution to journal › Article
- 2018
-
Mark
Clinical phenotype, atrophy, and small vessel disease in APOEε2 carriers with Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Consensus guidelines for lumbar puncture in patients with neurological diseases
(
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases : Results from a large multicenter cohort
(
- Contribution to journal › Article
-
Mark
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
(
- Contribution to journal › Article
- 2015
-
Mark
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
(
- Contribution to journal › Article